Total Funding
91
78
Total FundingPost-IPO Equity raised
Growth Score
-6 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
19412
DiagnosTear develops a novel device that helps in diagnosing, monitoring, and companion diagnostics of dry eye syndrome.
- Eran Eilat: CMO and Founder
BioLight Israeli Life Sciences Investments
About the Company
DiagnosTear develops a novel device that helps in diagnosing, monitoring, and companion diagnostics of dry eye syndrome. TeaRxTM is a diagnostic solution that delivers a multi-parameter, objective, rapid, simple, semi-quantitative analysis of tear film to identify one or more underlying causes of DES.
DiagnosTear was founded on 2013 and is
headquartered in Tel Aviv, Israel.
